Endpoints News ٢٦ فبراير ٢٠٢٦ Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Endpoints News ٢٠ فبراير ٢٠٢٦ Novartis to divest India unit to private equity-led consortium for $159M
FierceBiotech ١٨ فبراير ٢٠٢٦ Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Endpoints News ١٨ فبراير ٢٠٢٦ Novartis signs macrocyclic deal with Unnatural Products for $100M upfront
Endpoints News ١٨ فبراير ٢٠٢٦ Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results
FierceBiotech ٤ فبراير ٢٠٢٦ Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates
Endpoints News ١٣ يناير ٢٠٢٦ Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
Endpoints News ١٢ يناير ٢٠٢٦ Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’s